What is the first drug that was approved by the FDA to treat COVID-19?

Remdesivir is the first drug approved by the FDA for treatment of hospitalized COVID patients over the age of 12.

When was the COVID-19 treatment Paxlovid approved by the FDA?

FDA authorized Paxlovid (nirmatrelvir and ritonavir) in December 2021 for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing who are also at high risk for progression to severe COVID-19

Can the FDA help me to get a COVID-19 vaccination?

No. The FDA’s authority includes authorizing or approving COVID-19 vaccines for use in the U.S., but the FDA is not responsible for vaccine distribution. Search vaccines.gov, text your zip code to 438829, or call 1-800-232-0233 to find COVID-19 vaccine locations near you.

Can Paxlovid be used in treating COVID-19 infection?

Paxlovid and molnupiravir are the first oral medications to be approved for treating mild to moderate COVID-19. Both medications are authorized for high-risk people. They should be started within 5 days of first feeling symptoms of COVID-19.

When was the Moderna COVID-19 vaccine approved?

On January 31, 2022, the Food and Drug Administration (FDA) granted full approval to the Moderna COVID-19 vaccine for persons aged ≥18 years.

When was Pfizer-BioNTech COVID-19 vaccine approved?

Pfizer-BioNTech (COMIRNATY) received U.S. Food and Drug Administration (FDA) approval on August 23, 2021, for individuals 16 years of age and older. Once vaccines are approved by the FDA, companies can market the vaccines under brand names. COMIRNATY is the brand name for the Pfizer-BioNTech COVID-19 Vaccine.

What antiviral drugs are available for treatment of COVID-19?

Remdesivir is the only drug that is approved by the Food and Drug Administration (FDA) for the treatment of COVID-19. Ritonavir-boosted nirmatrelvir (Paxlovid), molnupiravir, and certain anti-SARS-CoV-2 monoclonal antibodies (mAbs) have received Emergency Use Authorizations from the FDA for the treatment of COVID-19.